Today's CNBC MarketWrap

Wednesday, Nov. 28, 2007 Today's top 5 stories on CNBC

1. Fed's Kohn Comments: The Fed's vice chairman Donald Kohn speaks on financial markets & central banking, reports CNBC's Steve Liesman.

2. Beige Book Highlights: Takeaways from the Fed's latest beige book report, with CNBC's Steve Liesman & Diana Olick.

3. Bear Cuts Jobs: Bear Stearns will cut 650 jobs, about four percent of its workforce, reports CNBC's Rebecca Jarvis.

4. Stop Trading!: Mad Money host Jim Cramer shares his stock picks and pans with CNBC's Erin Burnett

5. Make Me A Supermodel: Sam's Club kicks off its new line up of diamond rings, with Niki Taylor, Bravo's Make Me a Supermodel host and CNBC's Becky Quick.

Click here to view all of today's Top stories

Behind the Wheel: U.S. Car Buyers: What's Giving Them The "Jitters?" CNBC reporter Phil Lebeau blogs on the fearful American car buyer and what's keeping them from purchasing a new car or truck right now. Click here to view posting.

Tune in to CNBC tomorrow to watch the market unfold

1. XBOX MELTDOWN: The world's largest software company is facing a potentially huge, possibly class-action lawsuit and in preparation has already set aside $1 billion to address the problem presented by faulty XBOX 360s that literally melt down when they run certain of the company's gaming software. It's a big holiday headache that has MSFT hurting but Nintendo and Sony grinning. Jim Goldman digs into what Microsoft is saying and what's it's doing to confront the crisis to avoid a hit to its stock price. Jane Wells covers the XBOX consumers and reveals what gamers, bloggers and retailers are saying in response.

2. DOUBLE-DUTY STENTS: Abbott takes its first drug-coated stent before an FDA advisory committee Thursday but it's not an easy road to approval. Questions have been raised about safety data backing the stent that would give Abbott a slice of the $4 billion market. If the stent gets approval, it hits the market with double-force: Boston Scientific would market the very same drug-coated stent under the brand name Promus under the terms of the Guidant deal. Mike Huckman examines the decision and what it means for this growing pharmaceutical sector..

3. DELL EARNINGS: As the company moves to a business selling juiced-up machines to consumers worldwide, investors are looking to Dell's earnings for a gauge of the health of U.S. corporate technology spending. Analysts expect net income to rise to 35 cents a share and sales to reach $15.3 billion. Jim Goldman is live with the earnings report and Wall Street's reaction.

4. GOP DEBATE ROUNDUP: The Republican Presidential candidates met for a first-of-its-kind debate hosted by YouTube and CNN's Anderson Cooper Wednesday night in St. Petersburg, FL. John Harwood round-ups the winners and losers..

5. SMOKING OUT LUNG CANCER: Lung Cancer kills more people than Breast, Prostate and Colon cancer combined. So why is funding for research so anemic? Survivors say its all about the stigma. So Laura Geller Makeup, one of the largest private cosmetics companies in the U.S, and Joan's Legacy--a lung cancer foundation are teaming up to deliver a unique product to an underserved market. The brand new brow brushes are a big hit with survivors and others...giving funding to the foundation and Geller's bottom line. Darby Dunn reports.

CNBC Investing Tools

To unsubscribe to this email click here
If this e-mail was forwarded to you and you would like to subscribe to CNBC's Daily Market Wrap, please click here